ArticleFrontiers in immunology2025

Predicting recurrence and recurrence-free survival in initially unresectable hepatocellular carcinoma: a novel nomogram for patients undergoing conversion hepatectomy with lenvatinib, PD-1 inhibitor, and interventional therapy.

Cheng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.